Coronary artery disease and kidney disease
Authors:
MUDr. David Zemánek
Authors place of work:
Kardiologická klinika FN Motol a 2. LF UK Praha
Published in the journal:
Kardiol Rev Int Med 2005, 7(4): 191-194
Category:
Editorial
Summary
The patient with chronic kidney disease (CKD) and coronary artery disease (CAD) presents special challenges. CKD ranks among the risk factors for the development, the course and the success of the treatment of CAD and on the other hand cardiovascular disease is the major cause of morbidity and mortality of the patients with CKD. This report reviews the scope of the challenge concerning the pathophysiology of this disease, clinical presentation, diagnosis and treatment of these patients.
Keywords
coronary artery disease – chronic kidney disease – diagnosis - treatment
Zdroje
1. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease. Circulation 2003; 108: 2154-2169.
2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-119.
3. Schwarz U, Buzello M, Ritz E et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15: 218-220.
4. Ganesh SK, Stack AG, Levin NW et al. Association of elevated serum phosphate, calcium x phosphate product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138.
5. Shlipak MG, Fried LF, Crump C et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92.
6. De Filippi C, Wasserman S, Rosanio S et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patient undergoing long-term hemodialysis. JAMA 2003; 290: 353-359.
7. Chew DP, Bhatt DL, Kimball W et al. Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials. Am J Cardiol 2003; 92: 919-923.
8. Mann JFE, Gerstein JC, Pogue J et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-636.
9. Ma JZ, Ebben J, Xia H, Collins AJ. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999; 10: 610-619.
10. Besarab A, Bolton WK, Browne JK et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590.
11. Boaz M, Smetana S, Weinstein T et al. Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE): randomized placebo-controlled trial. Lancet 2000; 356: 1213-1218.
12. Schoebel FC, Gradaus F, Ivens K et al. Restenosis after elective coronary balloon angioplasty in patient with end stage renal disease: a case control study using quantitative coronary angiography. Heart 1997; 78: 337-342.
13. Le Feuvre C, Dambrin G, Helft G et al. Clinical outcome following coronary angioplasty in dialysis patients: a case control study in the era of coronary stenting. Heart 2001; 85: 556-560.
14. Lemos PA, Chourmouzios AA, Heye A et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 2005; 95: 167-172.
15. Best PJ, Berger PB, Barry DR et al. Impact of mild or moderate chronic kidney disease on frequency of restenosis. J Am Coll Cardiol 2004; 44: 1786-1791.
16. Sadeghi HM, Stone GW, Grines CL et al. Impact of renal insufficiency in patient undergoing primary angioplasty for acute myocardial infarction. Circulation 2003; 108: 2769-2775.
17. Zemánek D, Málek I, Pirk J. Střednědobé výsledky dialyzovaných nemocných pacientů po chirurugické revaskularizaci myokardu. Cor Vasa 2002; 44: S137.
18. Szczech LA, Best PJ, Crowley E et al. for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Outcome of patients with chronic renal insufficiency in BARI. Circulation 2002; 105: 2253-2258.
19. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of long-term survival after revascularization in patient with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003; 92: 509-514.
20. Hemmelgarn BR, Southern D, Culleton BF et al. Survival after coronary revascularization among patient with kidney disease. Circulation 2004; 110: 1890-1895.
21. Birck R, Krzossok S, Markowetz F et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003; 362: 598-603.
22. Dimeny EM. Cardiovascular disease after renal transplantation. Kidney Int 2002; 6: S78-84.
23. Kasiske BL, Ramos EL, Gaston RS et al. The evaluation of renal transplant candidates: clinical practice guidelines. J Am Soc Nephrol 1995; 6: 1-34.
Štítky
Paediatric cardiology Internal medicine Cardiac surgery CardiologyČlánok vyšiel v časopise
Cardiology Review
2005 Číslo 4
Najčítanejšie v tomto čísle
- Left Main Coronary Artery Occlusion Induced Acute Myocardial Infarction: Experiences from the Beginning of the Third Millenium
- Losartan in clinical studies
- Rehabilitation after myocardial infarction (III)
- Coronary artery disease and kidney disease